EM-1421, or terameprocol, a synthetic Nordihydroguaiaretic acid derivative, acts as a non-selective lipoxygenase inhibitor with potent antiviral and antitumor properties, making it a promising candidate for therapeutic development in oncology and infectious diseases.
Usually ships within 24 hours.